BioMatrix Flex

With Drug Coating

Biosensors | BioMatrix Flex / With Drug Coating

Biosensors | BioMatrix Flex / With Drug Coating

Biosensors | BioMatrix Flex / With Drug Coating

Biosensors | BioMatrix Flex / With Drug Coating

Biosensors | BioMatrix Flex / With Drug Coating

Biosensors | BioMatrix Flex / With Drug Coating

Безопасность и эффективность, подтвержденная
3х летним наблюдением в условиях реальной клинической практики

– Исследование LEADERS показало снижение уровня МАСЕ на 18% по сравнению со стентом Сypher® Select™²
– Отчетливые тенденции к преимуществу BioМatrix Flex™

From Drug-Eluting Stents to Bare-Metal Stents*

Absence of Polymer Carrier and Drug on the Inner Surface of the Stent:
  • Early endothelialization comparable to bare-metal stents¹
  • More precise drug delivery to target tissues
  • Reduced systemic impact

Combination of BA9™ Drug Technology and Biodegradable Polylactic Acid Polymer Demonstrates Vasomotor Preservation:
  • Sirolimus stent group showed vasoconstriction after stimulation
Biolimus A9™ stent group showed a normal vasodilation response after stimulation

Highest Lipophilicity Among Macrolides:
  • Minimizes systemic impact and reduces drug circulation in the bloodstream
  • High lipophilicity ensures rapid tissue absorption

Improved Access to Side Branches:
  • Enhanced initial cell opening facilitates easier access to side branches

*Studies on porcine models indicate polymer coating absorption occurs within 6–9 months. All data is proprietary to Biosensors International.
  • All data is proprietary to Biosensors International.
  • Serruys, P.W., presentation at TCT 2010

Bioabsorbable Coating Applied to Vessel Wall Surface

Proven Safety of DES Through the Use of a Biodegradable Polymer on the Vessel Wall-Facing Surface